Sisram Medical Ltd., headquartered in Israel, is a prominent player in the medical aesthetics industry, specialising in innovative laser and energy-based solutions. Founded in 2001, the company has established a strong presence in key markets across Europe, Asia, and North America, focusing on advanced technologies for skin rejuvenation, hair removal, and body contouring. With a commitment to research and development, Sisram Medical offers a diverse range of products, including the renowned Alma Lasers systems, which are distinguished by their efficacy and safety. The company has achieved significant milestones, including numerous regulatory approvals and a growing portfolio of patents, solidifying its position as a leader in the aesthetic medical field. Through its dedication to quality and innovation, Sisram Medical continues to set benchmarks in the industry, enhancing patient outcomes and practitioner satisfaction.
How does Sisram Medical Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Sisram Medical Ltd's score of 25 is lower than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sisram Medical Ltd, headquartered in Israel (IL), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. The company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to reducing its carbon footprint at this time. As there are no emissions figures or reduction initiatives available, it is unclear how Sisram Medical Ltd is addressing climate change or its environmental impact. The absence of data may reflect a broader industry context where companies are increasingly expected to disclose their emissions and set ambitious targets in line with global climate goals. Without specific emissions data or commitments, it is challenging to assess Sisram Medical Ltd's position in the context of climate action and sustainability efforts.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Sisram Medical Ltd has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

